Patents by Inventor Sophie E. Bogdan

Sophie E. Bogdan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 7-(2-imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
    Patent number: 6423724
    Abstract: This invention involves involves the use of compounds having the following structure: wherein: (a) R is unsubstituted C1-C3 alkanyl or alkenyl; and (b) R′ is selected from hydrogen; unsubstituted C1-C3 alkanyl or alkenyl; unsubstituted C1-C3 alkylthio or alkoxy; hydroxy; thiol; cyano; and halo; for preventing or treating of disorders modulated by alpha-2 adrenoceptors. The subject invention also involves novel compounds and compositions.
    Type: Grant
    Filed: September 24, 1998
    Date of Patent: July 23, 2002
    Assignee: The Procter & Gamble Company
    Inventors: Thomas Lee Cupps, Sophie E. Bogdan, Raymond T. Henry, Russell James Sheldon
  • 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
    Patent number: 5916900
    Abstract: This invention involves involves the use of compounds having the following structure: ##STR1## wherein: (a) R is unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; and(b) R' is selected from hydrogen; unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; unsubstituted C.sub.1 -C.sub.3 alkylthio or alkoxy; hydroxy; thiol; cyano; and halo;for preventing or treating of disorders modulated by alpha-2 adrenoceptors.The subject invention also involves novel compounds and compositions.
    Type: Grant
    Filed: November 25, 1996
    Date of Patent: June 29, 1999
    Assignee: The Procter & Gamble Company
    Inventors: Thomas Lee Cupps, Sophie E. Bogdan, Raymond T. Henry, Russell James Sheldon
  • 6-(2-imidazolinylamino) quinolines useful as alpha-2 adrenoceptor agonists
    Patent number: 5804587
    Abstract: The subject invention relates to compounds having the structure: ##STR1## as defined in the claims, and to pharmaceutical compositions containing such compounds, and the use of such compounds for preventing or treating of disorders modulated by alpha-2 adrenoceptors.
    Type: Grant
    Filed: November 25, 1996
    Date of Patent: September 8, 1998
    Assignee: The Procter & Gamble Company
    Inventors: Thomas Lee Cupps, Peter J. Maurer, Jeffrey J. Ares, Raymond T. Henry, Russell James Sheldon, Glen E. Mieling, Sophie E. Bogdan
  • 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
    Patent number: 5576437
    Abstract: The subject invention involves methods of treating nasal congestion comprising administration, to a human or lower animal in need of such treatment of a safe and effective amount of a compound having the following structure: ##STR1## wherein: (a) R is unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; and(b) R' is selected from hydrogen; unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; unsubstituted C.sub.1 -C.sub.3 alkylthio or alkoxy; hydroxy; thiol; cyano; and halo.The subject invention also involves the use of such compounds for preventing or treating other respiratory, ocular and/or gastrointestinal disorders. The subject invention also involves novel compounds having the above structure wherein R' is hydrogen or fluoro or cyano.
    Type: Grant
    Filed: August 18, 1994
    Date of Patent: November 19, 1996
    Assignee: The Procter & Gamble Company
    Inventors: Thomas L. Cupps, Sophie E. Bogdan
  • 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 andrenoceptor agonists
    Patent number: 5541210
    Abstract: The subject invention involves compounds having the following structure: ##STR1## wherein: (a) R is unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl;(b) R' is selected from hydrogen; unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; unsubstituted C.sub.1 -C.sub.3 alkylthio or alkoxy; hydroxy; thiol; cyano; and halo; and(c) R' is selected from hydrogen, methyl, ethyl and i-propyl.The subject invention also involves pharmaceutical compositions containing such novel compounds, compositions thereof and the use of such compounds for preventing or treating respiratory, ocular and/or gastrointestinal disorders.
    Type: Grant
    Filed: June 29, 1995
    Date of Patent: July 30, 1996
    Assignee: The Procter & Gamble Company
    Inventors: Thomas L. Cupps, Sophie E. Bogdan
  • 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
    Patent number: 5478858
    Abstract: The subject invention involves compounds having the following structure: ##STR1## wherein: (a) R is unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl;(b) R' is selected from hydrogen; unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; unsubstituted C.sub.1 -C.sub.3 alkylthio or alkoxy; hydroxy; thiol; cyano; and halo; and(c) R" is selected from hydrogen, methyl, ethyl and i-propyl.The subject invention also involves pharmaceutical compositions containing such novel compounds, and the use of such compounds for preventing or treating respiratory, ocular and/or gastrointestinal disorders.
    Type: Grant
    Filed: December 8, 1994
    Date of Patent: December 26, 1995
    Assignee: The Procter & Gamble Company
    Inventors: Thomas L. Cupps, Sophie E. Bogdan